Nubia Munoz

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. ncbi Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
  2. ncbi Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, Lyon, France
    Int J Epidemiol 37:536-46. 2008
  3. ncbi Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 107:127-33. 2003
  4. ncbi Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies
    Catherine de Martel
    International Agency for Research on Cancer, 69372 Lyon, France
    Int J Cancer 126:1992-6. 2010
  5. ncbi Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:326-33. 2006
  6. ncbi Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study
    Martyn Plummer
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Cancer Causes Control 14:805-14. 2003
  7. ncbi Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Nubia Munoz
    International Agency for Research on Cancer, Lyons, France
    N Engl J Med 348:518-27. 2003
  8. ncbi Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
  9. ncbi Against which human papillomavirus types shall we vaccinate and screen? The international perspective
    Nubia Munoz
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:278-85. 2004
  10. ncbi Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions
    Martyn Plummer
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    J Natl Cancer Inst 99:1328-34. 2007

Detail Information

Publications18

  1. ncbi Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
    ..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
  2. ncbi Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, Lyon, France
    Int J Epidemiol 37:536-46. 2008
    ..Smoking increases the risk of squamous-cell carcinoma of the cervix, but it is not clear whether smoking increases the risk of acquisition or persistence of human papillomavirus (HPV) infection...
  3. ncbi Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 107:127-33. 2003
    ..A vaccine against HPV 16 and 18 may be effective in more than three-quarters of ICC in the study area...
  4. ncbi Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies
    Catherine de Martel
    International Agency for Research on Cancer, 69372 Lyon, France
    Int J Cancer 126:1992-6. 2010
    ....
  5. ncbi Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:326-33. 2006
    ..Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types...
  6. ncbi Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study
    Martyn Plummer
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Cancer Causes Control 14:805-14. 2003
    ..This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer...
  7. ncbi Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Nubia Munoz
    International Agency for Research on Cancer, Lyons, France
    N Engl J Med 348:518-27. 2003
    ..Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed...
  8. ncbi Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
    ..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
  9. ncbi Against which human papillomavirus types shall we vaccinate and screen? The international perspective
    Nubia Munoz
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:278-85. 2004
    ..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
  10. ncbi Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions
    Martyn Plummer
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    J Natl Cancer Inst 99:1328-34. 2007
    ..pylori genes to the severity and progression of precancerous lesions is not well defined...
  11. ncbi Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:2148-53. 2006
    ....
  12. ncbi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
    Jennifer S Smith
    International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
    J Infect Dis 185:324-31. 2002
    ..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
  13. ncbi Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
    ..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
  14. ncbi Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
    Gary Clifford
    International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon Cedex 08, France
    Vaccine 24:S3/26-34. 2006
    ..After HPV-16/18, the six most common HPV types are the same in all world regions, namely 31, 33, 35, 45, 52 and 58; these account for an additional 20% of cervical cancers worldwide...
  15. ncbi Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 19:2379-88. 2010
    ..Few human papillomavirus (HPV) seroprevalence studies have been carried out in women from low-resource countries...
  16. ncbi From causality to prevention - the example of cervical cancer: my personal contribution to this fascinating history
    Nubia Munoz
    IARC, Lyon, France
    Public Health Genomics 12:368-71. 2009
    ..The history of the generation of an hypothesis linking human papillomavirus to cervical cancer, as well as a summary of the various molecular epidemiological studies undertaken to confirm such hypothesis are described...
  17. ncbi Chapter 1: HPV in the etiology of human cancer
    Nubia Munoz
    Institut CatalĂ  d Oncologia ICO, 24 Quai Fulchiron, Lyon, France
    Vaccine 24:S3/1-10. 2006
    ..Genetic and immunological host factors and viral factors other than type, such as variants of type, viral load and viral integration, are likely to be important but have not been clearly identified...
  18. ncbi Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population
    Martyn Plummer
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    J Natl Cancer Inst 99:137-46. 2007
    ..Epidemiologic evidence suggests that a diet rich in fresh fruit and vegetables could be a protective factor against this disease. This effect may be mediated through antioxidant vitamins...